Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	122.15	62.41	33.79	43.05	65.47	112.35
Short-Term Investments	73.42	128.61	35.71	24.69	17.38	-
Cash & Short-Term Investments	195.57	191.01	69.5	67.74	82.85	112.35
Cash Growth	-1.98%	174.85%	2.60%	-18.24%	-26.26%	2566.65%
Accounts Receivable	13.25	11.66	4.8	16.12	7.19	1.42
Other Receivables	6.7	11.6	5.71	1.26	1.11	0.11
Receivables	19.94	23.26	10.51	17.38	8.3	1.53
Inventory	3.07	1.74	1.97	-	-	-
Prepaid Expenses	7.26	7	4.05	1.82	1.69	0.89
Other Current Assets	-	-	-	-	-	0.29
Total Current Assets	225.84	223.01	86.03	86.94	92.83	115.06
Property, Plant & Equipment	2.24	1.7	1.01	1.53	1.78	2.03
Long-Term Investments	75.32	47.88	6.01	-	20	15.42
Goodwill	4.7	4.7	4.7	4.7	-	-
Other Intangible Assets	5.47	6.42	68.99	69.23	-	-
Other Long-Term Assets	-	1.02	11.38	9.94	0.72	0.44
Total Assets	313.58	284.73	178.13	172.33	115.34	132.94

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.67	2.48	13.08	13.99	3.61	0.52
Accrued Expenses	7.22	21.31	18.31	18.97	7.21	2.52
Short-Term Debt	-	-	-	37.7	-	-
Current Portion of Leases	0.63	0.42	0.42	0.54	0.49	0.37
Current Income Taxes Payable	18.53	13.71	-	-	-	-
Other Current Liabilities	1.32	1.36	2.26	2.52	0.71	0.82
Total Current Liabilities	41.37	39.28	34.07	73.72	12.02	4.23
Long-Term Debt	-	61.93	59.5	5.07	12.8	-
Long-Term Leases	0.6	0.86	0.37	0.46	0.84	1.24
Other Long-Term Liabilities	32.68	28.01	44.52	31.22	14.55	0.36
Total Liabilities	74.65	130.07	138.46	110.46	40.22	5.82

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	609.62	588.46	555.3	472.66	436.27	396.96
Retained Earnings	-356.21	-422.06	-505.29	-399.78	-353.73	-267.03
Treasury Stock	-10.98	-10.98	-10.98	-10.98	-7.54	-2.81
Comprehensive Income & Other	-3.51	-0.76	0.63	-0.04	0.11	-
Shareholders' Equity	238.92	154.66	39.67	61.86	75.12	127.12
Total Liabilities & Equity	313.58	284.73	178.13	172.33	115.34	132.94

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.23	63.21	60.3	43.77	14.13	1.61
Net Cash (Debt)	194.34	127.81	9.2	23.97	68.72	110.74
Net Cash Growth	42.07%	1289.18%	-61.62%	-65.11%	-37.95%	-
Net Cash Per Share	3.21	2.23	0.20	0.68	1.99	3.72
Filing Date Shares Outstanding	59.5	58.71	54.12	41.85	34.54	34.42
Total Common Shares Outstanding	59.44	56.85	53.67	41.53	34.54	35.01
Working Capital	184.47	183.73	51.96	13.22	80.81	110.83
Book Value Per Share	4.02	2.72	0.74	1.49	2.17	3.63
Tangible Book Value	228.75	143.54	-34.03	-12.06	75.12	127.12
Tangible Book Value Per Share	3.85	2.52	-0.63	-0.29	2.17	3.63
Machinery	-	0.66	1.36	1.51	1.28	1.05
Leasehold Improvements	-	0.14	0.71	0.71	0.71	0.72

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error